Abstract P02-02: First results of RLY-4008, a potent and highly selective FGFR2 inhibitor in a first-in-human study in patients with FGFR2-altered cholangiocarcinoma and multiple solid tumors

Name: Work Video:
Duration: 3 min 30 s
Lipika Goyal; Mitesh J. Borad; Vivek Subbiah; Amit Mahipal; Suneel D. Kamath; Kabir Mody; Robin Katie Kelley; Richard D. Kim; Vaibhav Sahai; Anthony B. El-Khoueiry; Efrat Dotan; Oleg Schmidt‐Kittler; Jinshan Shen; Kai Yu Jen; Alicia Deary; Wei Guo; Mahesh V. Padval; Cori Ann Sherwin; Charles Ferté; Beni B. Wolf; Alison M. Schram
{'id': 'https://openalex.org/W4200164884', 'doi': 'https://doi.org/10.1158/1535-7163.targ-21-p02-02', 'title': 'Abstract P02-02: First results of RLY-4008, a potent and highly selective FGFR2 inhibitor in a first-in-human study in patients with FGFR2-altered cholangiocarcinoma and multiple solid tumors', 'display_name': 'Abstract P02-02: First results of RLY-4008, a potent and highly selective FGFR2 inhibitor in a first-in-human study in patients with FGFR2-altered cholangiocarcinoma and multiple solid tumors', 'publication_year': 2021, 'publication_date': '2021-12-01', 'ids': {'openalex': 'https://openalex.org/W4200164884', 'doi': 'https://doi.org/10.1158/1535-7163.targ-21-p02-02'}, 'language': 'en', 'primary_location': {'is_oa': False, 'landing_page_url': 'https://doi.org/10.1158/1535-7163.targ-21-p02-02', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S48437117', 'display_name': 'Molecular Cancer Therapeutics', 'issn_l': '1535-7163', 'issn': ['1535-7163', '1538-8514'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320273', 'host_organization_name': 'American Association for Cancer Research', 'host_organization_lineage': ['https://openalex.org/P4310320273'], 'host_organization_lineage_names': ['American Association for Cancer Research'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, 'type': 'article', 'type_crossref': 'journal-article', 'indexed_in': ['crossref'], 'open_access': {'is_oa': False, 'oa_status': 'closed', 'oa_url': None, 'any_repository_has_fulltext': False}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5058709133', 'display_name': 'Lipika Goyal', 'orcid': 'https://orcid.org/0000-0002-9777-6221'}, 'institutions': [{'id': 'https://openalex.org/I4210087915', 'display_name': 'Massachusetts General Hospital', 'ror': 'https://ror.org/002pd6e78', 'country_code': 'US', 'type': 'healthcare', 'lineage': ['https://openalex.org/I4210087915', 'https://openalex.org/I48633490']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Lipika Goyal', 'raw_affiliation_strings': ['1Massachusetts General Hospital, Boston, MA,'], 'affiliations': [{'raw_affiliation_string': '1Massachusetts General Hospital, Boston, MA,', 'institution_ids': ['https://openalex.org/I4210087915']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5018257387', 'display_name': 'Mitesh J. Borad', 'orcid': 'https://orcid.org/0000-0003-2700-2658'}, 'institutions': [{'id': 'https://openalex.org/I4210125099', 'display_name': 'Mayo Clinic in Arizona', 'ror': 'https://ror.org/03jp40720', 'country_code': 'US', 'type': 'healthcare', 'lineage': ['https://openalex.org/I1330342723', 'https://openalex.org/I4210125099']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Mitesh Borad', 'raw_affiliation_strings': ['2Mayo Clinic, Phoenix, AZ,'], 'affiliations': [{'raw_affiliation_string': '2Mayo Clinic, Phoenix, AZ,', 'institution_ids': ['https://openalex.org/I4210125099']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5043675371', 'display_name': 'Vivek Subbiah', 'orcid': 'https://orcid.org/0000-0002-6064-6837'}, 'institutions': [{'id': 'https://openalex.org/I1343551460', 'display_name': 'The University of Texas MD Anderson Cancer Center', 'ror': 'https://ror.org/04twxam07', 'country_code': 'US', 'type': 'healthcare', 'lineage': ['https://openalex.org/I1343551460']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Vivek Subbiah', 'raw_affiliation_strings': ['3The University of Texas M.D. Anderson Cancer Center, Houston, TX,'], 'affiliations': [{'raw_affiliation_string': '3The University of Texas M.D. Anderson Cancer Center, Houston, TX,', 'institution_ids': ['https://openalex.org/I1343551460']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5002142386', 'display_name': 'Amit Mahipal', 'orcid': 'https://orcid.org/0000-0002-1111-8333'}, 'institutions': [{'id': 'https://openalex.org/I4210125099', 'display_name': 'Mayo Clinic in Arizona', 'ror': 'https://ror.org/03jp40720', 'country_code': 'US', 'type': 'healthcare', 'lineage': ['https://openalex.org/I1330342723', 'https://openalex.org/I4210125099']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Amit Mahipal', 'raw_affiliation_strings': ['4Mayo Clinic, Rochester, MN,'], 'affiliations': [{'raw_affiliation_string': '4Mayo Clinic, Rochester, MN,', 'institution_ids': ['https://openalex.org/I4210125099']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5023582019', 'display_name': 'Suneel D. Kamath', 'orcid': 'https://orcid.org/0000-0003-0117-366X'}, 'institutions': [{'id': 'https://openalex.org/I1316902750', 'display_name': 'Cleveland Clinic', 'ror': 'https://ror.org/03xjacd83', 'country_code': 'US', 'type': 'healthcare', 'lineage': ['https://openalex.org/I1316902750']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Suneel Kamath', 'raw_affiliation_strings': ['5Cleveland Clinic, Taussig Cancer Institute, Cleveland, OH,'], 'affiliations': [{'raw_affiliation_string': '5Cleveland Clinic, Taussig Cancer Institute, Cleveland, OH,', 'institution_ids': ['https://openalex.org/I1316902750']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5062280376', 'display_name': 'Kabir Mody', 'orcid': 'https://orcid.org/0000-0003-3254-2990'}, 'institutions': [{'id': 'https://openalex.org/I4210146710', 'display_name': 'Mayo Clinic in Florida', 'ror': 'https://ror.org/03zzw1w08', 'country_code': 'US', 'type': 'healthcare', 'lineage': ['https://openalex.org/I1330342723', 'https://openalex.org/I4210146710']}, {'id': 'https://openalex.org/I4210086066', 'display_name': 'Nemours Children’s Clinic', 'ror': 'https://ror.org/00f76x039', 'country_code': 'US', 'type': 'healthcare', 'lineage': ['https://openalex.org/I4210086066', 'https://openalex.org/I4210108049']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Kabir Mody', 'raw_affiliation_strings': ['6Mayo Clinic, Jacksonville, FL,'], 'affiliations': [{'raw_affiliation_string': '6Mayo Clinic, Jacksonville, FL,', 'institution_ids': ['https://openalex.org/I4210146710', 'https://openalex.org/I4210086066']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5113910810', 'display_name': 'Robin Katie Kelley', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210167126', 'display_name': 'UCSF Helen Diller Family Comprehensive Cancer Center', 'ror': 'https://ror.org/05yndxy10', 'country_code': 'US', 'type': 'facility', 'lineage': ['https://openalex.org/I180670191', 'https://openalex.org/I4210110664', 'https://openalex.org/I4210167126']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Robin Katie Kelley', 'raw_affiliation_strings': ['7UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA,'], 'affiliations': [{'raw_affiliation_string': '7UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA,', 'institution_ids': ['https://openalex.org/I4210167126']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5045482037', 'display_name': 'Richard D. Kim', 'orcid': 'https://orcid.org/0000-0002-8448-844X'}, 'institutions': [{'id': 'https://openalex.org/I3019308854', 'display_name': 'Moffitt Cancer Center', 'ror': 'https://ror.org/01xf75524', 'country_code': 'US', 'type': 'healthcare', 'lineage': ['https://openalex.org/I3019308854']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Richard Kim', 'raw_affiliation_strings': ['8Moffitt Cancer Center, Tampa, FL,'], 'affiliations': [{'raw_affiliation_string': '8Moffitt Cancer Center, Tampa, FL,', 'institution_ids': ['https://openalex.org/I3019308854']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5076767039', 'display_name': 'Vaibhav Sahai', 'orcid': 'https://orcid.org/0000-0003-1892-1548'}, 'institutions': [{'id': 'https://openalex.org/I27837315', 'display_name': 'University of Michigan–Ann Arbor', 'ror': 'https://ror.org/00jmfr291', 'country_code': 'US', 'type': 'education', 'lineage': ['https://openalex.org/I27837315']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Vaibhav Sahai', 'raw_affiliation_strings': ['9University of Michigan, Ann Arbor, MI,'], 'affiliations': [{'raw_affiliation_string': '9University of Michigan, Ann Arbor, MI,', 'institution_ids': ['https://openalex.org/I27837315']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5013744957', 'display_name': 'Anthony B. El-Khoueiry', 'orcid': 'https://orcid.org/0000-0002-9053-3841'}, 'institutions': [{'id': 'https://openalex.org/I4210117038', 'display_name': 'USC Norris Comprehensive Cancer Center', 'ror': 'https://ror.org/01nmyfr60', 'country_code': 'US', 'type': 'healthcare', 'lineage': ['https://openalex.org/I2800154431', 'https://openalex.org/I4210117038']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Anthony El-Khoueiry', 'raw_affiliation_strings': ['10USC/Norris Comprehensive Cancer Center, Los Angeles, CA,'], 'affiliations': [{'raw_affiliation_string': '10USC/Norris Comprehensive Cancer Center, Los Angeles, CA,', 'institution_ids': ['https://openalex.org/I4210117038']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5072144086', 'display_name': 'Efrat Dotan', 'orcid': 'https://orcid.org/0000-0002-5762-512X'}, 'institutions': [{'id': 'https://openalex.org/I1289437631', 'display_name': 'Fox Chase Cancer Center', 'ror': 'https://ror.org/0567t7073', 'country_code': 'US', 'type': 'healthcare', 'lineage': ['https://openalex.org/I1289437631', 'https://openalex.org/I4210122924']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Efrat Dotan', 'raw_affiliation_strings': ['11Fox Chase Cancer Center, Philadelphia, PA,'], 'affiliations': [{'raw_affiliation_string': '11Fox Chase Cancer Center, Philadelphia, PA,', 'institution_ids': ['https://openalex.org/I1289437631']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5065462815', 'display_name': 'Oleg Schmidt‐Kittler', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210131505', 'display_name': 'Sage Therapeutics (United States)', 'ror': 'https://ror.org/03t9rxt77', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I4210131505']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Oleg Schmidt-Kittler', 'raw_affiliation_strings': ['12Relay Therapeutics, Inc., Cambridge, MA,'], 'affiliations': [{'raw_affiliation_string': '12Relay Therapeutics, Inc., Cambridge, MA,', 'institution_ids': ['https://openalex.org/I4210131505']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5102406332', 'display_name': 'Jinshan Shen', 'orcid': 'https://orcid.org/0000-0003-1428-9098'}, 'institutions': [{'id': 'https://openalex.org/I4210131505', 'display_name': 'Sage Therapeutics (United States)', 'ror': 'https://ror.org/03t9rxt77', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I4210131505']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Jinshan Shen', 'raw_affiliation_strings': ['12Relay Therapeutics, Inc., Cambridge, MA,'], 'affiliations': [{'raw_affiliation_string': '12Relay Therapeutics, Inc., Cambridge, MA,', 'institution_ids': ['https://openalex.org/I4210131505']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5042279631', 'display_name': 'Kai Yu Jen', 'orcid': 'https://orcid.org/0009-0006-9310-7940'}, 'institutions': [{'id': 'https://openalex.org/I4210131505', 'display_name': 'Sage Therapeutics (United States)', 'ror': 'https://ror.org/03t9rxt77', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I4210131505']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Kai Yu Jen', 'raw_affiliation_strings': ['12Relay Therapeutics, Inc., Cambridge, MA,'], 'affiliations': [{'raw_affiliation_string': '12Relay Therapeutics, Inc., Cambridge, MA,', 'institution_ids': ['https://openalex.org/I4210131505']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5063785361', 'display_name': 'Alicia Deary', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210131505', 'display_name': 'Sage Therapeutics (United States)', 'ror': 'https://ror.org/03t9rxt77', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I4210131505']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Alicia Deary', 'raw_affiliation_strings': ['12Relay Therapeutics, Inc., Cambridge, MA,'], 'affiliations': [{'raw_affiliation_string': '12Relay Therapeutics, Inc., Cambridge, MA,', 'institution_ids': ['https://openalex.org/I4210131505']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5071679949', 'display_name': 'Wei Guo', 'orcid': 'https://orcid.org/0000-0001-5487-0720'}, 'institutions': [{'id': 'https://openalex.org/I4210131505', 'display_name': 'Sage Therapeutics (United States)', 'ror': 'https://ror.org/03t9rxt77', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I4210131505']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Wei Guo', 'raw_affiliation_strings': ['12Relay Therapeutics, Inc., Cambridge, MA,'], 'affiliations': [{'raw_affiliation_string': '12Relay Therapeutics, Inc., Cambridge, MA,', 'institution_ids': ['https://openalex.org/I4210131505']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5075029290', 'display_name': 'Mahesh V. Padval', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210131505', 'display_name': 'Sage Therapeutics (United States)', 'ror': 'https://ror.org/03t9rxt77', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I4210131505']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Mahesh Padval', 'raw_affiliation_strings': ['12Relay Therapeutics, Inc., Cambridge, MA,'], 'affiliations': [{'raw_affiliation_string': '12Relay Therapeutics, Inc., Cambridge, MA,', 'institution_ids': ['https://openalex.org/I4210131505']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5024845646', 'display_name': 'Cori Ann Sherwin', 'orcid': 'https://orcid.org/0009-0008-8818-4567'}, 'institutions': [{'id': 'https://openalex.org/I4210131505', 'display_name': 'Sage Therapeutics (United States)', 'ror': 'https://ror.org/03t9rxt77', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I4210131505']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Cori Ann J. Sherwin', 'raw_affiliation_strings': ['12Relay Therapeutics, Inc., Cambridge, MA,'], 'affiliations': [{'raw_affiliation_string': '12Relay Therapeutics, Inc., Cambridge, MA,', 'institution_ids': ['https://openalex.org/I4210131505']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5111883100', 'display_name': 'Charles Ferté', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210131505', 'display_name': 'Sage Therapeutics (United States)', 'ror': 'https://ror.org/03t9rxt77', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I4210131505']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Charles Ferte', 'raw_affiliation_strings': ['12Relay Therapeutics, Inc., Cambridge, MA,'], 'affiliations': [{'raw_affiliation_string': '12Relay Therapeutics, Inc., Cambridge, MA,', 'institution_ids': ['https://openalex.org/I4210131505']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5061909254', 'display_name': 'Beni B. Wolf', 'orcid': 'https://orcid.org/0009-0008-3809-4280'}, 'institutions': [{'id': 'https://openalex.org/I4210131505', 'display_name': 'Sage Therapeutics (United States)', 'ror': 'https://ror.org/03t9rxt77', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I4210131505']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Beni Wolf', 'raw_affiliation_strings': ['12Relay Therapeutics, Inc., Cambridge, MA,'], 'affiliations': [{'raw_affiliation_string': '12Relay Therapeutics, Inc., Cambridge, MA,', 'institution_ids': ['https://openalex.org/I4210131505']}]}, {'author_position': 'last', 'author': {'id': 'https://openalex.org/A5088495181', 'display_name': 'Alison M. Schram', 'orcid': 'https://orcid.org/0000-0002-6070-2413'}, 'institutions': [{'id': 'https://openalex.org/I39965400', 'display_name': 'Kettering University', 'ror': 'https://ror.org/03rcspa57', 'country_code': 'US', 'type': 'education', 'lineage': ['https://openalex.org/I39965400']}, {'id': 'https://openalex.org/I1334819555', 'display_name': 'Memorial Sloan Kettering Cancer Center', 'ror': 'https://ror.org/02yrq0923', 'country_code': 'US', 'type': 'healthcare', 'lineage': ['https://openalex.org/I1334819555']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Alison M. Schram', 'raw_affiliation_strings': ['13Memorial Sloan Kettering Cancer Center, New York, NY.'], 'affiliations': [{'raw_affiliation_string': '13Memorial Sloan Kettering Cancer Center, New York, NY.', 'institution_ids': ['https://openalex.org/I39965400', 'https://openalex.org/I1334819555']}]}], 'institution_assertions': [], 'countries_distinct_count': 1, 'institutions_distinct_count': 14, 'corresponding_author_ids': [], 'corresponding_institution_ids': [], 'apc_list': None, 'apc_paid': None, 'fwci': 0.797, 'has_fulltext': False, 'cited_by_count': 10, 'citation_normalized_percentile': {'value': 0.638317, 'is_in_top_1_percent': False, 'is_in_top_10_percent': False}, 'cited_by_percentile_year': {'min': 87, 'max': 88}, 'biblio': {'volume': '20', 'issue': '12_Supplement', 'first_page': 'P02', 'last_page': '02'}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T12287', 'display_name': 'Fibroblast Growth Factor Research', 'score': 0.999, 'subfield': {'id': 'https://openalex.org/subfields/1312', 'display_name': 'Molecular Biology'}, 'field': {'id': 'https://openalex.org/fields/13', 'display_name': 'Biochemistry, Genetics and Molecular Biology'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}, 'topics': [{'id': 'https://openalex.org/T12287', 'display_name': 'Fibroblast Growth Factor Research', 'score': 0.999, 'subfield': {'id': 'https://openalex.org/subfields/1312', 'display_name': 'Molecular Biology'}, 'field': {'id': 'https://openalex.org/fields/13', 'display_name': 'Biochemistry, Genetics and Molecular Biology'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}, {'id': 'https://openalex.org/T11364', 'display_name': 'Cholangiocarcinoma and Gallbladder Cancer Studies', 'score': 0.9826, 'subfield': {'id': 'https://openalex.org/subfields/2746', 'display_name': 'Surgery'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T10269', 'display_name': 'Epigenetics and DNA Methylation', 'score': 0.9658, 'subfield': {'id': 'https://openalex.org/subfields/1312', 'display_name': 'Molecular Biology'}, 'field': {'id': 'https://openalex.org/fields/13', 'display_name': 'Biochemistry, Genetics and Molecular Biology'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}], 'keywords': [], 'concepts': [{'id': 'https://openalex.org/C22979827', 'wikidata': 'https://www.wikidata.org/wiki/Q5137311', 'display_name': 'Cmax', 'level': 3, 'score': 0.67735875}, {'id': 'https://openalex.org/C112705442', 'wikidata': 'https://www.wikidata.org/wiki/Q323936', 'display_name': 'Pharmacokinetics', 'level': 2, 'score': 0.65547794}, {'id': 'https://openalex.org/C2777288759', 'wikidata': 'https://www.wikidata.org/wiki/Q4164182', 'display_name': 'Dosing', 'level': 2, 'score': 0.62885267}, {'id': 'https://openalex.org/C197934379', 'wikidata': 'https://www.wikidata.org/wiki/Q2047938', 'display_name': 'Adverse effect', 'level': 2, 'score': 0.5834296}, {'id': 'https://openalex.org/C71924100', 'wikidata': 'https://www.wikidata.org/wiki/Q11190', 'display_name': 'Medicine', 'level': 0, 'score': 0.547069}, {'id': 'https://openalex.org/C98274493', 'wikidata': 'https://www.wikidata.org/wiki/Q128406', 'display_name': 'Pharmacology', 'level': 1, 'score': 0.4579202}, {'id': 'https://openalex.org/C126322002', 'wikidata': 'https://www.wikidata.org/wiki/Q11180', 'display_name': 'Internal medicine', 'level': 1, 'score': 0.35693246}, {'id': 'https://openalex.org/C143998085', 'wikidata': 'https://www.wikidata.org/wiki/Q162555', 'display_name': 'Oncology', 'level': 1, 'score': 0.34750986}], 'mesh': [], 'locations_count': 1, 'locations': [{'is_oa': False, 'landing_page_url': 'https://doi.org/10.1158/1535-7163.targ-21-p02-02', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S48437117', 'display_name': 'Molecular Cancer Therapeutics', 'issn_l': '1535-7163', 'issn': ['1535-7163', '1538-8514'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320273', 'host_organization_name': 'American Association for Cancer Research', 'host_organization_lineage': ['https://openalex.org/P4310320273'], 'host_organization_lineage_names': ['American Association for Cancer Research'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': None, 'sustainable_development_goals': [{'id': 'https://metadata.un.org/sdg/3', 'score': 0.79, 'display_name': 'Good health and well-being'}], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 0, 'referenced_works': [], 'related_works': ['https://openalex.org/W2413891776', 'https://openalex.org/W2389534144', 'https://openalex.org/W2374254312', 'https://openalex.org/W2371507726', 'https://openalex.org/W2371426955', 'https://openalex.org/W2360876458', 'https://openalex.org/W2355979670', 'https://openalex.org/W2353297249', 'https://openalex.org/W2348752634', 'https://openalex.org/W1978721469'], 'abstract_inverted_index': {'Abstract': [0], 'INTRODUCTION:': [1], 'Oncogenic': [2], 'FGFR2': [3, 30, 48, 136, 179, 214, 315, 387, 441, 511], 'alterations': [4, 137, 316], '(fusions/rearrangements,': [5], 'amplifications,': [6], 'mutations)': [7], 'are': [8], 'key': [9], 'drivers': [10], 'in': [11, 58, 240, 272, 283, 288, 323, 333, 339, 357, 390, 409, 513, 517], 'cholangiocarcinoma': [12, 521], '(CCA)': [13], 'and': [14, 28, 40, 50, 70, 97, 161, 174, 212, 226, 254, 286, 314, 346, 406, 442, 508, 522, 538], 'multiple': [15, 523], 'solid': [16, 60, 411, 524], 'tumors.': [17], 'Current': [18], 'pan-FGFR': [19], 'inhibitor': [20, 43, 512], '(FGFRi)': [21], 'therapy': [22], 'is': [23, 36], 'limited': [24], 'by': [25], 'off-isoform': [26, 428], 'toxicity': [27, 429], 'acquired': [29], 'kinase': [31], 'domain': [32], 'resistance': [33, 51, 180, 388, 450], 'mutations.': [34, 52], 'RLY-4008': [35, 73, 79, 118, 195, 306, 401, 445], 'a': [37, 55, 84, 88, 506, 514], 'highly': [38, 509], 'selective': [39, 438, 510], 'potent': [41, 507], 'oral': [42], 'designed': [44], 'to': [45, 64, 202, 231, 328, 351, 376, 448, 451], 'target': [46], 'both': [47], 'driver': [49], 'We': [53], 'initiated': [54], 'first-in-human': [56, 515], 'study': [57, 516], 'advanced': [59], 'tumors': [61, 525], 'patients': [62, 384, 518], '(pts)': [63], 'define': [65], 'the': [66, 233, 379, 424, 530], 'safety,': [67, 404], 'pharmacokinetics': [68], '(PK)': [69], 'efficacy': [71], 'of': [72, 106, 123, 145, 155, 242, 259, 321, 341, 440, 504, 529], '(NCT04526106).': [74], 'METHODS:': [75], 'Adult': [76], 'pts': [77, 109, 127, 130, 133, 157, 170, 243, 265, 299, 325, 342, 362, 369], 'received': [78], 'QD': [80, 204, 227, 289], 'or': [81, 192], 'BID': [82, 284], 'on': [83, 301, 418, 535], '4-week': [85], 'cycle': [86], 'following': [87], 'BOIN': [89], 'escalation': [90], 'design.': [91], 'Adverse': [92], 'events': [93], '(AEs),': [94], 'PK,': [95], 'ctDNA': [96, 176, 391], 'anti-tumor': [98, 309], 'activity': [99, 310, 408], '(RECIST': [100], '1.1)': [101], 'were': [102, 261, 277, 296, 396], 'assessed.': [103], 'RESULTS:': [104], 'As': [105], '16AUG21,': [107], '45': [108], '(35': [110], 'CCA;': [111], '10': [112], 'other)': [113], 'have': [114], 'been': [115, 224], 'treated': [116], 'with': [117, 171, 317, 337, 364, 370, 385, 423, 519], 'at': [119, 182, 186, 392, 398], 'total': [120], 'daily': [121], 'doses': [122], '30-200': [124], 'mg': [125], '(18': [126], 'BID;': [128], '27': [129], 'QD).': [131], '44': [132], 'had': [134, 158, 164, 177, 196, 266], 'oncogenic': [135], '(26': [138], 'fusions/13': [139], 'mutations/5': [140], 'amplifications).': [141], 'The': [142, 220], 'median': [143], 'number': [144], 'prior': [146, 159, 165, 172, 419], 'anti-neoplastic': [147], 'therapies': [148], 'was': [149, 331, 354, 432], '3': [150], '(range': [151, 303], '1-15).': [152], '94%': [153], '(33/35)': [154], 'CCA': [156, 169, 336, 361, 383], 'chemotherapy': [160], '69%': [162], '(24/35)': [163], 'FGFRi.': [166, 452], '56%': [167], '(9/16)': [168], 'FGFRi': [173, 358, 380, 420], 'evaluable': [175], '≥1': [178], 'mutation': [181], 'baseline,': [183, 393], 'most': [184], 'commonly': [185], 'positions': [187], '549': [188], '(8/9),': [189], '617': [190], '(3/9),': [191], '564': [193], '(2/9).': [194], 'rapid': [197], 'absorption': [198], '(Tmax': [199], '1-7h),': [200], 'half-life': [201], 'support': [203], 'dosing': [205], '(18-34': [206], 'h),': [207], 'dose-dependent': [208], 'exposure': [209], '(AUC;': [210], 'Cmax)': [211], 'predicted': [213], 'occupancy': [215], '&amp;gt;85%': [216], 'across': [217, 311], 'dose': [218, 228, 279, 312], 'levels.': [219], 'MTD': [221], 'has': [222, 446], 'not': [223], 'defined,': [225], 'exploration': [229], 'continues': [230], 'select': [232], 'optimal': [234], 'biologically': [235], 'efficacious': [236], 'dose.': [237], 'AEs': [238, 276, 295], 'occurring': [239], '&amp;gt;20%': [241], 'include': [244], 'stomatitis': [245], '(49%),': [246], 'palmar-plantar': [247], 'erythrodysesthesia': [248], '(PPE,': [249], '38%),': [250], 'dry': [251], 'mouth': [252], '(29%),': [253], 'nail': [255], 'toxicities': [256], '(22%),': [257], 'majority': [258], 'which': [260, 270], '≤Gr': [262], '2.': [263], '6': [264], 'Gr': [267, 292], '1-2': [268], 'retinopathy,': [269], 'resolved': [271], 'all': [273], 'cases.': [274], '5': [275], 'considered': [278], 'limiting': [280], 'toxicities:': [281], '4': [282], '(rash/PPE/mucositis/hyperbilirubinemia)': [285], '1': [287, 347], '(retinopathy).': [290], 'No': [291], '4/5': [293], 'drug-related': [294], 'seen.': [297, 433], '25': [298], 'remain': [300], 'treatment': [302], '1-37': [304], 'weeks).': [305], 'showed': [307], 'broad': [308], 'levels': [313], 'radiographic': [318], 'tumor': [319, 371, 412], 'reductions': [320], '≥10%': [322, 373], '59%': [324], '(19/32;': [326], '-11%': [327], '-83%).': [329, 352], 'Activity': [330, 353], 'seen': [332, 356], 'FGFRi-naïve,': [334], 'FGFR2-fusion+': [335, 360, 382], 'PRs': [338], '50%': [340], '(3/6,': [343], '2': [344], 'confirmed': [345], 'pending': [348], 'confirmation;': [349], '-56%': [350], 'also': [355], 'pre-treated': [359, 381], '(N=16)': [363], '16': [365], 'SD,': [366], 'including': [367, 414], '9': [368], 'reduction': [372], '(from': [374], '-12%': [375], '-35%).': [377], 'Of': [378], 'detectable': [386], 'mutations': [389], '78%': [394], '(7/9)': [395], 'undetectable': [397], 'C2D1.': [399], 'CONCLUSION:': [400], 'demonstrates': [402], 'promising': [403], 'tolerability,': [405], 'clinical': [407], 'FGFR2-altered': [410, 520], 'pts,': [413], 'those': [415], 'who': [416], 'progressed': [417], 'therapy.': [421], 'Consistent': [422], 'FGFR2-selective': [425], 'mechanism,': [426], 'minimal': [427], '(FGFR1-hyperphosphatemia;': [430], 'FGFR4-diarrhea)': [431], 'These': [434], 'encouraging': [435], 'data': [436], 'validate': [437], 'targeting': [439], 'suggest': [443], 'that': [444], 'potential': [447], 'overcome': [449], 'Citation': [453], 'Format:': [454], 'Lipika': [455], 'Goyal,': [456], 'Mitesh': [457], 'Borad,': [458], 'Vivek': [459], 'Subbiah,': [460], 'Amit': [461], 'Mahipal,': [462], 'Suneel': [463], 'Kamath,': [464], 'Kabir': [465], 'Mody,': [466], 'Robin': [467], 'Katie': [468], 'Kelley,': [469], 'Richard': [470], 'Kim,': [471], 'Vaibhav': [472], 'Sahai,': [473], 'Anthony': [474], 'El-Khoueiry,': [475], 'Efrat': [476], 'Dotan,': [477], 'Oleg': [478], 'Schmidt-Kittler,': [479], 'Jinshan': [480], 'Shen,': [481], 'Kai': [482], 'Yu': [483], 'Jen,': [484], 'Alicia': [485], 'Deary,': [486], 'Wei': [487], 'Guo,': [488], 'Mahesh': [489], 'Padval,': [490], 'Cori': [491], 'Ann': [492], 'J.': [493], 'Sherwin,': [494], 'Charles': [495], 'Ferte,': [496], 'Beni': [497], 'Wolf,': [498], 'Alison': [499], 'M.': [500], 'Schram.': [501], 'First': [502], 'results': [503], 'RLY-4008,': [505], '[abstract].': [526], 'In:': [527], 'Proceedings': [528], 'AACR-NCI-EORTC': [531], 'Virtual': [532], 'International': [533], 'Conference': [534], 'Molecular': [536], 'Targets': [537], 'Cancer': [539, 548], 'Therapeutics;': [540], '2021': [541], 'Oct': [542], '7-10.': [543], 'Philadelphia': [544], '(PA):': [545], 'AACR;': [546], 'Mol': [547], 'Ther': [549], '2021;20(12': [550], 'Suppl):Abstract': [551], 'nr': [552], 'P02-02.': [553]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W4200164884', 'counts_by_year': [{'year': 2024, 'cited_by_count': 1}, {'year': 2023, 'cited_by_count': 6}, {'year': 2022, 'cited_by_count': 3}], 'updated_date': '2024-12-24T05:21:33.594294', 'created_date': '2021-12-31'}
Publication Information

Basic Information

Access and Citation

AI Researcher Chatbot

Primary Location

Authors

Topics

Keywords

Related Works
